A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

242

Participants

Timeline

Start Date

February 27, 2025

Primary Completion Date

August 31, 2029

Study Completion Date

August 31, 2029

Conditions
Small Cell Lung Cancer
Interventions
BIOLOGICAL

Gocatamig

IV infusion

BIOLOGICAL

Ifinatamab Deruxtecan (I-DXd)

IV infusion

BIOLOGICAL

Durvalumab

IV infusion

Trial Locations (28)

4102

RECRUITING

Princess Alexandra Hospital ( Site 5300), Wooloongabba

14263

RECRUITING

Roswell Park Cancer Institute ( Site 1107), Buffalo

28040

RECRUITING

Hospital Clinico San Carlos... ( Site 3316), Madrid

RECRUITING

Hospital Universitario Fundación Jiménez Díaz-START Madrid-FJD ( Site 3315), Madrid

28050

RECRUITING

Hospital Universitario HM Sanchinarro ( Site 3313), Madrid

29010

RECRUITING

Hospital Universitario Virgen de la Victoria ( Site 3312), Málaga

33136

RECRUITING

University of Miami Hospital and Clinics, Sylvester Cancer Center ( Site 1111), Miami

37203

RECRUITING

Sarah Cannon Research Institute ( Site 7001), Nashville

60637

RECRUITING

University of Chicago ( Site 1108), Chicago

97213

RECRUITING

Providence Portland Medical Center ( Site 1101), Portland

3109601

RECRUITING

Rambam Health Care Campus ( Site 3202), Haifa

5265601

RECRUITING

Sheba Medical Center ( Site 3201), Ramat Gan

7500921

RECRUITING

FALP ( Site 2100), Santiago

8420383

RECRUITING

Bradfordhill ( Site 2101), Santiago

9103102

RECRUITING

Shaare Zedek Medical Center ( Site 3200), Jerusalem

02215

RECRUITING

Dana Farber Cancer Institute ( Site 1105), Boston

07601

RECRUITING

John Theurer Cancer Center at Hackensack University Medical Center ( Site 1103), Hackensack

464-8681

RECRUITING

Aichi Cancer Center ( Site 5000), Nagoya

277-0882

RECRUITING

National Cancer Center Hospital East ( Site 5001), Kashiwa

573-1191

RECRUITING

Kansai Medical University Hospital ( Site 5004), Hirakata

135-8550

RECRUITING

Cancer Institute Hospital of JFCR ( Site 5002), Koto

03080

RECRUITING

Seoul National University Hospital ( Site 5100), Seoul

06351

RECRUITING

Samsung Medical Center ( Site 5101), Seoul

08036

RECRUITING

HOSPITAL CLÍNIC DE BARCELONA ( Site 3310), Eixample

08907

RECRUITING

Institut Català d'Oncologia - L'Hospitalet ( Site 3317), L'Hospitalet de Llobregat

08035

RECRUITING

Hospital Universitari Vall d'Hebron ( Site 3311), Barcelona

06230

RECRUITING

Hacettepe Universite Hastaneleri ( Site 3410), Ankara

06800

RECRUITING

Ankara Bilkent Sehir Hastanesi ( Site 3412), Ankara

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Daiichi Sankyo

INDUSTRY

lead

Merck Sharp & Dohme LLC

INDUSTRY